NewAmsterdam Pharma Co. N.V. NAMS
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
NewAmsterdam Pharma Co. N.V. is a pharmaceutical company focused on the research, development, and commercialization of transformative therapies addressing cardiovascular diseases. The company's primary mission is to innovate in the cardiovascular space by introducing medications that meet the evolving needs of patient…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryNetherlands
Employees68
TickerNAMS
Statistics
Market Cap$3.49B
Revenue (TTM)$22.5M
Net Income-$203.8M
Net Margin-905.7%
EPS$-1.72
P/E-17.05
P/S157.39
P/B5.33
EV/EBITDA-13.56
ROE-29.5%
Dividend Yield2.17%
Price$29.91
Data: Twelve Data · Revenue = mcap / P/S